In a study, hepcidin and serum hsCRP predicted the erythropoietin resistance index in patients on hemodialysis. Hepcidin, a cysteine-rich polypeptide mainly produced by hepatocytes, might serve as a ...

BOSTON -- The SGLT-2 inhibitor dapagliflozin (Farxiga) was tied to a suppression in plasma hepcidin concentrations in patients with type 2 diabetes, researchers reported here. Compared with baseline, ...

High levels of circulating hepcidin are associated with low erythropoietin levels in patients with CKD. Elevated hepcidin may be due in part to EPO deficiency. Failure to reduce hepcidin levels could ...

Please provide your email address to receive an email when new articles are posted on . Single dose of DISC-0974 shows positive safety and tolerability profiles among healthy patients. This dose also ...

A research team from United Kingdom described the use of radioimmunoassay to demonstrate and measure hepcidin-25 in various biological fluids. They provided evidence for the first time of the presence ...

June 1, 2012 (Paris, France) — Vitamin D supplementation is safe and economic for patients with chronic kidney disease (CKD); it can also decrease the need for erythropoietin-stimulating agents and ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — The route by which SGLT2 inhibitors increase hematocrit and hemoglobin levels in adults with type 2 ...

Rusfertide significantly improves hematocrit control and reduces the mean number of phlebotomies in patients who are phlebotomy-dependent despite standard care. The Food and Drug Administration (FDA) ...

Long-term protective effects of the angiotensin-receptor blocker telmisartan on epirubucin-induced inflammation, oxidative stress, and myocardial dysfunction. Hepcidin 1st tertile 6/47 (13%) 4/41 (10% ...

The importance of recognizing that iron is phlogistic . . . is that such recognition helps us to understand that in giving iron to patients with inflammatory joint disease, we supply the means for ...